Novartis and Medicines for Malaria Venture announce positive efficacy and safety data for a novel treatment for babies <5 kg with malaria There is currently no evidence-based treatment for the smallest babies with malaria The CALINA study tested a new ratio and dose of Coartem® (artemether- lumefantrine) to account for metabolic...

Novartis Entresto receives positive CHMP opinion for pediatric heart failure If subsequently approved, Entresto will be the first and only approved therapy for the treatment of symptomatic chronic heart failure patients aged 1 to <18 years in the European Union Pediatric...

How Classroom Design is Critical to Student Wellbeing in a Post-Pandemic World VICTORIA, British Columbia, May 26, 2021 (GLOBE NEWSWIRE) -- During the pandemic, students have experienced emotional and psychological stress of varying degrees resulting in increased reports of...